Inventor · disambiguated record
Pengcheng Patrick Shao
Also filed as: SHAO PENGCHENG P · SHAO PENGCHENG PATRICK
12 granted patents·12 pending applications·31 citations·filing 2005–2025
85Inventor score
Files withMERCK SHARP & DOHME9SHANGHAI ARGO BIOPHARMACEUTICAL CO LTD6CHAKRAVARTY PRASUN K2MITOTHERAPEUTIX LLC2CHAKRAVARTY PASUN K1
Top patents by PatentIndex Score
24 records- 0188US9981970B2Bicyclic ureas and thiadiazolidine-1, 1-dioxides as CETP inhibitorsLIU JIAN·Filed 2014·Granted May 29, 2018·12 cites·10 claims
- 0284US10086000B2Tricyclic compounds as inhibitors of mutant IDH enzymesMERCK SHARP & DOHME·Filed 2015·Granted Oct 2, 2018·3 cites·17 claims
- 0384US8871738B2Fused bicyclic oxazolidinone CETP inhibitorMERCK SHARP & DOHME·Filed 2012·Granted Oct 28, 2014·8 cites·60 claims
- 0479US9376408B2Therapeutic thiazolidinone compoundsMERCK SHARP & DOHME·Filed 2013·Granted Jun 28, 2016·3 cites·16 claims
- 0576US9580396B2C6-spiro iminothiadiazine dioxides as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2013·Granted Feb 28, 2017·3 cites·16 claims
- 0670US9663534B2Fused bicyclic isoxazolines as inhibitors of cholesterol ester transfer proteinMERCK SHARP & DOHME·Filed 2014·Granted May 30, 2017·1 cites·15 claims
- 0765US10508108B2Tricyclic compounds as inhibitors of mutant IDH enzymesMERCK SHARP & DOHME·Filed 2015·Granted Dec 17, 2019·1 cites·20 claims
- 0865US2024084304A1Composition and method for inhibiting angiotensinogen (agt) protein expressionSHANGHAI ARGO BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0958US2025297250A1Composition and method for inhibiting expression of protein lpa(apo(a))SHANGHAI ARGO BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1055US2025257356A1Composition and method for inhibiting expression of protein lpa(apo(a))SHANGHAI ARGO BIOPHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1154US9346825B2Fused bicyclic oxazolidinone CETP inhibitorMERCK SHARP & DOHME·Filed 2014·Granted May 24, 2016·0 cites·16 claims
- 1253US2024376475A1Compositions and methods for inhibiting expression of angiopoietin-like 3 (angptl3) proteinSHANGHAI ARGO BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1351US8304434B2Substituted aryl sulfone derivatives as calcium channel blockersCHAKRAVARTY PRASUN K·Filed 2008·Granted Nov 6, 2012·0 cites·9 claims
- 1451US2023092615A1Compositions and methods for inhibiting expressing of methylation-controlled j-protein (mcj)MITOTHERAPEUTIX LLC·Filed 2021·Application pending·0 cites
- 1550US2025145999A1Compositions and methods for inhibiting expression of prekallikrein (pkk) proteinSHANGHAI ARGO BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1649US2024271141A1Composition and method for inhibiting expression of hepatitis b virus (hbv)proteinSHANGHAI ARGO BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1747US12440496B2Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetesMERCK SHARP & DOHME LLC·Filed 2020·Granted Oct 14, 2025·0 cites·15 claims
- 1847US2008280873A1Biaryl Substituted Pyrazinones as Sodium Channel BlockersLIANG JUN·Filed 2005·Application pending·0 cites
- 1946US2022175934A1Multivalent ligand clusters for targeted delivery of therapeutic agentsMITOTHERAPEUTIX LLC·Filed 2020·Application pending·0 cites
- 2045US2011172223A1Substituted Aryl Sulfone Derivatives as Calcium Channel BlockersCHAKRAVARTY PRASUN K·Filed 2009·Application pending·0 cites
- 2142US2009048227A1Substituted-1-Phthalazinamines As Vr- 1 AntagonistsCHAKRAVARTY PASUN K·Filed 2006·Application pending·0 cites
- 2235US10011572B2Monocyclic isoxazolines as inhibitors of cholesterol ester transfer proteinMERCK SHARP & DOHME·Filed 2015·Granted Jul 3, 2018·0 cites·18 claims
- 2334US10442819B2Tricyclic compounds as inhibitors of mutant IDH enzymesFISCHER CHRISTIAN·Filed 2015·Granted Oct 15, 2019·0 cites·16 claims
- 2434US2018230166A1Bicyclic heterocycles as inhibitors of cholesterol ester transfer proteinMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pengcheng Patrick Shao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →